Contact for Price and Free PhD Formula
Our 5-in-1 Adaptogenic Complex scientifically modulates the HPA Axis and GABA pathways to rapidly reduce cortisol levels. It features 600mg of HPLC-verified Ashwagandha (5% Withanolides) combined with L-Theanine and Zinc to significantly improve sleep quality, sharpen mental focus under stress, and provide natural testosterone support for peak male vitality.
Dominate the High-Growth $3.8B Adaptogen Market
Ashwagandha search interest is at an all-time high, with the global market projected to reach $3.8B by 2036. Our 5-in-1 complex captures three high-value segments—Stress Management, Sleep Quality, and Male Vitality—with a single SKU. By moving first, your brand can own the category in the fastest-growing Asia-Pacific and established North American markets.
10x Cost Advantage with Same Clinical Molecule
Maximize your profit margins without compromising efficacy. Our formula uses non-branded 5% standardized Withanolides, delivering the exact same clinical active molecules as patented extracts but at a 90% lower raw material cost. You pay for what works, not for brand licensing fees, allowing your brand to offer competitive pricing while maintaining premium quality.
3-Layer Precision Formula for Maximum Bioavailability
We go beyond simple ingredients by targeting three biological pathways: the HPA Axis for adrenal stress, the GABA pathway for neural calming, and the HPG Axis for hormonal support. Enhanced with 95% Piperine, this formula ensures maximum nutrient absorption. Every ingredient earns its place through molecular mechanism, providing a “high-performance” feel that drives consumer loyalty.
Global Manufacturing Excellence & Rapid Scaling
Scale your independent station with a partner that understands global compliance. Our GMP-certified, ISO 9001, and Halal-certified facilities provide HPLC testing for every batch to ensure Withanolide potency. We offer low MOQs starting from 500 units, professional Pantone label matching, and a rapid 20–30 day lead time, ensuring your brand stays ahead of competitors.
FAQ ABOUT Ashwagandha 5-in-1 Adaptogenic Complex:
Q: What is the difference between non-branded ashwagandha and KSM-66 or Sensoril?
A: KSM-66 and Sensoril are proprietary standardized extracts of Withania somnifera with branded extraction processes and clinical research programs. Non-branded Ashwagandha 5% Withanolides uses identical active compounds (withanolides) at the same standardized concentration (5% HPLC-verified). The primary difference is commercial: branded extracts cost $200–400/kg ($9–18 per bottle of raw material), while non-branded equivalents cost $20–35/kg. For B2B private label brands, the choice is between paying for the active molecule (non-branded, scientifically equivalent) or paying for the brand name (branded, higher COGS). NuCoreBio provides non-branded standard as default, with KSM-66 upgrade available for brands targeting premium positioning that requires the brand recognition.
Q: How does Zinc Gluconate contribute to testosterone support in this formula?
A: Zinc plays two specific roles in the testosterone pathway. First, zinc is an essential cofactor for LH (luteinizing hormone) receptor function in testicular Leydig cells — these are the cells that convert cholesterol to testosterone in response to LH signals. Ashwagandha’s documented testosterone-boosting mechanism partly operates through increased LH secretion; if Leydig cells lack sufficient zinc, their response to this LH signal is attenuated. Second, zinc directly inhibits aromatase (CYP19A1), the enzyme that converts testosterone to estradiol, which helps maintain favorable testosterone:estradiol ratios. Human studies show zinc deficiency alone can reduce serum testosterone by up to 50%. Zinc Gluconate from NuCoreBio’s procurement price list costs ¥40/kg — approximately ¥0.03 per bottle.
Q: What is the global market size for ashwagandha supplements?
A: The global ashwagandha root extract market was valued at $1.3 billion in 2025 and is projected to reach $3.8 billion by 2036, representing a CAGR of 10.3% (Future Market Insights, April 2026). Capsule and tablet formats hold approximately 47% of the market. North America accounts for approximately 37% of global market share. Asia-Pacific is the fastest-growing region at 9.3% CAGR. The supplement category covers three major consumer segments: stress management, sleep quality, and male vitality — allowing brand owners to position the same formula across multiple high-value demographics.
